LIMN
Liminatus Pharma, Inc. Class A Common Stock
NASDAQ: LIMN · HEALTHCARE · BIOTECHNOLOGY
$0.20
-0.15% today
Updated 2026-04-30
Market cap
$9.09M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.43
Dividend yield
—
52W range
$0 – $34
Volume
5.0M
Liminatus Pharma, Inc. Class A Common Stock (LIMN) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
0 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-146.0%
Most recent quarter
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-4.6%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-8.7%
2025-10-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.30 | — | $0.64 | $0.64 | -0.5% |
| 2025-10-06 | $-0.07 | — | $1.73 | $1.58 | -8.7% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | — | $-0.30 | — | — | — |
| 2025-09-30 | $0.00 | $-0.07 | — | — | — |
| 2025-06-30 | — | $0.00 | — | — | — |
| 2025-03-31 | — | $-0.12 | — | — | — |
| 2024-12-31 | — | $-0.12 | — | — | — |
| 2024-09-30 | — | $-0.09 | — | — | — |
| 2024-06-30 | — | $-0.07 | — | — | — |
| 2024-03-31 | — | $-0.12 | — | — | — |
| 2023-12-31 | — | $-0.07 | — | — | — |
| 2023-09-30 | — | $-0.04 | — | — | — |
| 2023-06-30 | — | $0.03 | — | — | — |
| 2023-03-31 | — | $-0.08 | — | — | — |
Frequently asked questions
Has Liminatus Pharma, Inc. Class A Common Stock beaten earnings estimates?
Liminatus Pharma, Inc. Class A Common Stock has beaten Wall Street EPS estimates in 0 of its last 8 quarterly reports.
How does LIMN stock react to earnings?
LIMN stock has moved an average of -4.6% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.